The government has been covering the costs
The American government has covered the cost of vaccines distributed in the country since they were developed and started being distributed in late 2020. It bought more than 500 million doses from Pfizer, and paid between $20 and $30 each.
According to the Centers for Disease Control and Prevention, more than 265 million people, or 80% of the U.S. population, are fully vaccinated against COVID-19. But fewer than 20 million have taken the latest booster, signaling that demand is dropping precipitously.
And while the cost seems astronomical, Pfizer reportedly said that it expects people who have private health insurance or coverage through public programs like Medicare or Medicaid won’t have to pay out of pocket for their shots.
More: 3 healthcare stocks that could boost your portfolio
Don't miss
- Commercial real estate has beaten the stock market for 25 years — but only the super rich could buy in. Here's how even ordinary investors can become the landlord of Walmart, Whole Foods or Kroger
- Car insurance premiums in America are through the roof — and only getting worse. But 5 minutes could have you paying as little as $29/month
- These 5 magic money moves will boost you up America's net worth ladder in 2024 — and you can complete each step within minutes. Here's how
Fewer people getting boosted
Vaccine producers have been in a bit of a pickle. As demand for the vaccine has waned, investors' concerns about a drop in earnings have been growing.
Analysts surveyed by Factset had said they expected the company’s sales to decline given the anticipated slowdown in vaccinations. And while the price hike will help the company cushion the blow of softening demand, the announced increase by Pfizer was higher than many people expected.
And it will likely have repercussions for other vaccine manufacturers, like Moderna.
Moderna’s shares are down 46% this year — but the company did see a 9% boost last week when news of Pfizer’s plans was released. Moderna, for its part, is also expected to raise the price of its vaccine to a more affordable $60, according to Barron’s.
And while this might be comforting news for investors, it’s not all that comforting for anyone who still needs a shot or a boost.
What to read next
- Cost-of-living in America is still out of control — use these 3 'real assets' to protect your wealth today), no matter what the US Fed does or says
- Jeff Bezos and Oprah Winfrey invest in this asset to keep their wealth safe — you may want to do the same in 2024
- Stop crushing your retirement dreams with wealth-killing costs and headaches — here are 10 'must-haves' when choosing a trading platform (and 1 option that has them all)
